ABSTRACT Background Prostate cancer (PCa) is a leading cause of cancer-related death of
men worldwide. There is an urgent need to develop novel biomarkers for PCa prognosis …

Background Prostate cancer, the second most prevalent malignancy among men, poses a
significant threat to affected patients' well-being due to its poor prognosis. Novel biomarkers …

Long noncoding RNAs (lncRNAs) are involved in transcriptional regulation, and their
deregulation is associated with the development of various human cancers, including …

Prostate cancer (PCa) is the second most frequently diagnosed male cancer, and no
treatments exist for effective inhibition of metastatic spread of PCa. Long non-coding RNA …

Long non-coding RNAs (lncRNAs) are transcripts with sizes larger than 200 nucleotides and
no/small open reading frame that cannot produce functional proteins. The number of these …

Although the key roles of long non-coding RNAs (lncRNAs) in multiple diseases are well
documented, the relationship between the lncRNA copy number and expression is …

In the last few years lncRNAs have gained increasing attention among the scientific
community, thanks to the discovery of their implication in many physio-pathological …

Although several therapeutic options have been shown to improve survival of most patients
with prostate cancer, progression to castration-refractory state continues to present …

Renal cell carcinoma, bladder cancer, and prostate cancer are the most widespread
genitourinary tumors. Their treatment and diagnosis have significantly evolved over recent …

Noncoding RNAs are proclaimed to be expressed in various cancer types and one such
type is found to be pancreatic ductal adenocarcinoma (PDAC). The long noncoding RNAs …